At EpicentRx™ we’re focused on Remission:
Possible through the development of novel therapies designed to target inflammatory diseases and supportive care conditions of unmet medical need.

Tony Reid, M.D. Ph.D.

EpicentRx Chief Executive Officer
30-year practicing GI oncologist

“The next frontier is more than just new ways of targeting chronic diseases with multiple causative factors. Patient quality of life during treatment must drive the discussion. It’s a change in perspective, a call for innovation.”

PRETECT Platform

The Phase 3 investigational product, RRx-001 is from a portfolio that targets inflammatory and supportive care unmet medical needs.

AdAPT Platform

The AdAPT program’s lead clinical stage candidate, AdAPT-001, is an immune checkpoint-stimulating anticancer immunotherapy.

eLoop Device

The “eLoop” proprietary device is designed for optimized delivery of IV administered treatments.
pulsing dot

Explore our Pipeline

LEARN MORE

Introducing PRETECT Platform lead clinical candidate RRx-001

Much of the pharmaceutical industry is based on a recycle and repurpose strategy, rebranding as new or “next generation” based on only minor modifications, which may or may not represent therapeutic improvements over originals.
white line and dot

See what makes RRx-001 different

LEARN MORE

Control inflammation, control the disease

RRx-001 inhibits the inflammasome

The Inflammasome is responsible for activation of inflammatory responses. With chronic inflammation tissue destruction that occurs outpaces the regeneration of damaged tissues. Eventually, over time, the normal function of these tissues is reduced or lost. In chronically inflamed tissues, which may result from unresolved sources of foreign bodies, irritants or infections, the inflammasome fuels an inflammatory response for weeks to months or even years, resulting in a range of metabolic, neurological, autoimmune disorders as well as in the initiation of cancer.

X

epicentrx EpicentRx, Inc. @epicentrx ·
2 Dec

The 1967 film, The Dirty Dozen, could have been called the “Dirty Cozen” given the degree of mind f**ery that occurs to convince a ragtag bunch of violent convicts to lead a suicide mission behind enemy lines. Read more here: https://bit.ly/3OCIf8S.

Reply on Twitter 1863663869656248737 Retweet on Twitter 1863663869656248737 Like on Twitter 1863663869656248737 1 X 1863663869656248737
epicentrx EpicentRx, Inc. @epicentrx ·
27 Nov

Fire up the Bat Signal. The combination of AdAPT-001 plus an immune checkpoint inhibitor signals the immune system to go on the offensive against tumors. Read more here: https://bit.ly/3VbW4OW. #BatSignal #TheBatman #AdAPT001

Reply on Twitter 1861795133307465885 Retweet on Twitter 1861795133307465885 Like on Twitter 1861795133307465885 2 X 1861795133307465885
epicentrx EpicentRx, Inc. @epicentrx ·
26 Nov

What’s the word this Thanksgiving? For the answer ask Peter Griffin from Family Guy and read this Thanksgiving e-card here: https://bit.ly/4fIXR6r.

Reply on Twitter 1861424661361315893 Retweet on Twitter 1861424661361315893 Like on Twitter 1861424661361315893 1 X 1861424661361315893
epicentrx EpicentRx, Inc. @epicentrx ·
25 Nov

The recent backdrop of the very polarizing US Presidential election serves as the central analogy for an EpicentRx-authored article about macrophages in the December edition of PharmaTimes. Read more here and cast your vote on this well-written article entitled “Outside the Box”:…

Reply on Twitter 1861122173701587119 Retweet on Twitter 1861122173701587119 Like on Twitter 1861122173701587119 1 X 1861122173701587119
Load More
858.947.6635
11099 North Torrey Pines Road
Suite 160
La Jolla, CA 92037
Follow Us
Subscribe to our newsletter

This field is for validation purposes and should be left unchanged.

© 2023 EpicentRx, Inc. All rights reserved.